Algeria to Withdraw 108 Common Medications: What Users Should Know
Algeria is facing the withdrawal of 108 medications deemed potentially harmful, according to a list published by the French medical journal "Prescrire". This list includes widely used drugs that are often prescribed without a prescription.
The implementation of this withdrawal is scheduled for early 2026, classifying these medications as having risks that outweigh their benefits. The most notable among them include:
• Smecta for treating gastrointestinal issues.
• Maxilase for alleviating sore throat.
• Toplexil as a cough remedy.
• Volgalin for managing dizziness.
* Growing Concerns Among Algerians
The announcement has raised numerous questions regarding the safety of these medications for public health, particularly among regular users.
Health expert Mohamed Kouach stated:
"Every medication is subject to safety standards regarding its use and potential short- and long-term side effects. New side effects can be discovered even decades after a drug is released, leading to decisions based on severity."
He added that the list does not necessarily imply that these medications are directly dangerous, but rather that their risks may outweigh their benefits for certain patients or in cases of excessive use.
He emphasized:
"Patients who have taken these medications do not require a specific treatment protocol, but the market withdrawal aims to protect public health until official data or confirmations from the World Health Organization are available."
He also noted that excessive medication use can be more harmful than the medication itself, as it may lead to additional health issues.
* Key Takeaway
The important message for Algerians is to consult a healthcare professional before taking any medications, even those that are commonly used, and to monitor dosages to avoid health complications, especially in light of this new list that includes familiar medications in daily life.
